You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pharmaceutical Solutions

Showing 1 - 25 of 3,002
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Infertility, Female Trial in Cairo (Epifasi: Human chorionic gonadotrophin, Pregnyl: Human chorionic gonadotrophin)

Completed
  • Infertility, Female
  • Epifasi: Human chorionic gonadotrophin
  • Pregnyl: Human chorionic gonadotrophin
  • Cairo, Egypt
    Genuine Research Center GRC
Oct 22, 2020

Women Exposed to Rimegepant During Pregnancy

Active, not recruiting
  • Migraine
  • Research Triangle Park, North Carolina
    Research Triangle Institute d/b/a RTI Health Solutions
Feb 24, 2022

Hepatic Ascites Trial in Shibin Al Kawm (Oral standard diuretics therapy, Hypertonic saline solution, Etilefrine)

Completed
  • Hepatic Ascites
  • Oral standard diuretics therapy
  • +2 more
  • Shibīn Al Kawm, Menoufiya, Egypt
    National liver institute- menoufiya university
Mar 2, 2021

Graft Failure Trial in Australia, Canada, Israel (Emapalumab)

Terminated
  • Graft Failure
  • Melbourne, Australia
  • +4 more
Jul 25, 2022

Fatty Liver Trial in United States (Group 1 NRPT, Group 2 NRPT, Group 3 Placebo)

Completed
  • Fatty Liver
  • Group 1 NRPT
  • +2 more
  • Hialeah, Florida
  • +8 more
Oct 23, 2020

Acute Migraine Trial in United States (Vazegepant (BHV-3500))

Completed
  • Acute Migraine
  • Vazegepant (BHV-3500)
  • Huntsville, Alabama
  • +66 more
Feb 1, 2022

Post-SOPHrology Cancer Patients' anxieTY Report

Terminated
  • Cancer
  • Questionnaires
  • Saint-Priest-en-Jarez, France
    Institut de Cancérologie Lucien Neuwirth
Feb 7, 2022

Acute Gouty Arthritis Trial in United States (Anakinra 100 mg, Triamcinolone Acetonide 40 mg, Placebo to Anakinra 100 mg)

Completed
Has Results
  • Acute Gouty Arthritis
  • Anakinra 100 mg
  • +3 more
  • Birmingham, Alabama
  • +36 more
Jul 1, 2020

Hydration Trial in Kent (Control Group, Oral Rehydration Solution 1, Oral Rehydration Solution 2)

Recruiting
  • Hydration
  • Control Group
  • +3 more
  • Kent, Ohio
    Kent State University
Dec 14, 2022

Migraine Trial in United States (Placebo ZNS, ZNS)

Completed
  • Migraine
  • Phoenix, Arizona
  • +46 more
Jan 8, 2021

Healthy Trial in Beijing (99mTc niacinamide polyethylene glycol bicyclic RGD peptide (99mTc-3PRGD2))

Completed
  • Healthy
  • 99mTc niacinamide polyethylene glycol bicyclic RGD peptide (99mTc-3PRGD2)
  • Beijing, China
    Peking Union Medical College Hospital
Aug 7, 2019

ADHD Trial in United States (Dasotraline, Placebo Comparator)

Completed
  • Attention Deficit Hyperactivity Disorder
  • Dothan, Alabama
  • +42 more
Mar 16, 2021

Sepsis, Septic Shock, Shock, Toxic Trial in Manchester (hyperoncotic human albumin solution, Buffered crystalloid solutions)

Not yet recruiting
  • Sepsis
  • +2 more
  • hyperoncotic human albumin solution
  • Buffered crystalloid solutions
  • Manchester, Lancashire, United Kingdom
  • +1 more
Jul 5, 2022

Female Sexual Arousal Disorder Trial in United States (Sildenafil, Placebo)

Recruiting
  • Female Sexual Arousal Disorder
  • Mobile, Alabama
  • +50 more
Jun 24, 2021

Hepatic Encephalopathy Trial (Branched-chain amino acids (BCAA), enriched solution (Aminoleban) and L-ornithine L-aspartate

Not yet recruiting
  • Hepatic Encephalopathy
  • Branched-chain amino acids (BCAA), enriched solution (Aminoleban) and L-ornithine L-aspartate (LOLA)
  • Branched-chain amino acids (BCAA), enriched solution (Aminoleban)
  • (no location specified)
Sep 9, 2022

COVID-19, SARS-CoV 2, Severe Acute Respiratory Syndrome Coronavirus 2 Trial in San Francisco (Oral-B Mouth Sore mouthwash, Crest

Recruiting
  • COVID-19
  • +5 more
  • Oral-B Mouth Sore mouthwash
  • +4 more
  • San Francisco, California
    University Of California, San Francisco
May 17, 2022

Osteoarthritis, Knee, Osteoarthritis, Hip Trial in Worldwide (Fasinumab, Naproxen, Fasinumab-matching )

Completed
  • Osteoarthritis, Knee
  • Osteoarthritis, Hip
  • Mesa, Arizona
  • +138 more
Sep 10, 2021

Alzheimer, Mild Cognitive Impairment Trial in United States (Florbetapir F 18 PET Scan)

Active, not recruiting
  • Alzheimer Disease
  • Mild Cognitive Impairment
  • Florbetapir F 18 PET Scan
  • Anaheim, California
  • +76 more
Jun 9, 2021

Androgenetic Alopecia Trial in East Melbourne, Pascoe Vale South (prostaglandin F2a analogue in vehicle solution high dose,

Recruiting
  • Androgenetic Alopecia
  • prostaglandin F2a analogue in vehicle solution high dose
  • +3 more
  • East Melbourne, Victoria, Australia
  • +1 more
Dec 20, 2022

Degenerative Disc Disease Trial in Australia, United States (Rexlemestrocel-L, Rexlemestrocel-L + HA Mixture, Placebo)

Completed
Has Results
  • Degenerative Disc Disease
  • Birmingham, Alabama
  • +47 more
Jan 18, 2022

Presbyopia, Near Vision, Miosis Trial in Chandler, Glendale (Aceclidine+Brimonidine combination ophthalmic solution, Placebo,

Recruiting
  • Presbyopia
  • +3 more
  • Aceclidine+Brimonidine combination ophthalmic solution
  • +2 more
  • Chandler, Arizona
  • +1 more
Mar 2, 2023

Presbyopia, Refractive Errors, Eye Diseases Trial in United States (Aceclidine+Brimonidine combination ophthalmic solution,

Recruiting
  • Presbyopia
  • +4 more
  • Aceclidine+Brimonidine combination ophthalmic solution
  • +2 more
  • Glendale, California
  • +3 more
Aug 3, 2022

Cardiac Surgery Trial in Lund (Heart-lung machine primining solution which includes Mannitol, Heart-lung machine primining

Completed
  • Cardiac Surgery
  • Heart-lung machine primining solution which includes Mannitol
  • Heart-lung machine primining solution which does not include Mannitol
  • Lund, Skane, Sweden
    Thorax
Jan 14, 2022

Postoperative Hernia Trial in Granollers (Wound irrigation with amoxicillin-clavulanate in saline solution, Wound irrigation

Recruiting
  • Postoperative Hernia
  • Wound irrigation with amoxicillin-clavulanate in saline solution
  • Wound irrigation with a saline solution
  • Granollers, Barcelona, Spain
    Hospital General de Granollers
Aug 19, 2022

ADHD Trial in United States (SPD503-AM, SPD503-PM, Placebo)

Completed
Has Results
  • ADHD
  • Dothan, Alabama
  • +60 more
Jun 10, 2021